FDC Financial Statement Analysis
|
||
|
The Revenues of FDC have increased by 2.98% YoY .
The Earnings Per Share (EPS) of FDC has increased by 5.49 % YoY. |
||
FDC Last 5 Annual Financial Results
[BOM: 531599|NSE : FDC]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹2,171 Cr | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr |
| Expenses | ₹1,825 Cr | ₹1,783 Cr | ₹1,604 Cr | ₹1,534 Cr | ₹1,274 Cr |
| Operating Profit (Excl OI) | ₹346 Cr | ₹325 Cr | ₹339 Cr | ₹250 Cr | ₹254 Cr |
| Other Income | ₹114 Cr | ₹91 Cr | ₹102 Cr | ₹51 Cr | ₹76 Cr |
| Interest | ₹4.99 Cr | ₹4.51 Cr | ₹4.03 Cr | ₹4.09 Cr | ₹3.09 Cr |
| Depreciation | ₹59 Cr | ₹54 Cr | ₹40 Cr | ₹39 Cr | ₹37 Cr |
| Profit Before Tax | ₹375 Cr | ₹357 Cr | ₹396 Cr | ₹258 Cr | ₹289 Cr |
| Profit After Tax | ₹281 Cr | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr |
| Consolidated Net Profit | ₹281 Cr | ₹267 Cr | ₹305 Cr | ₹194 Cr | ₹216 Cr |
| Earnings Per Share (Rs) | ₹17.29 | ₹16.39 | ₹18.74 | ₹11.70 | ₹12.82 |
| PAT Margin (%) | 12.59 | 12.26 | 15.26 | 10.54 | 13.74 |
| ROE(%) | 11.81 | 12.19 | 14.96 | 9.84 | 11.71 |
| ROCE(%) | 15.93 | 16.52 | 19.62 | 13.27 | 15.78 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 5,462.8 Cr |
| Revenue (TTM) | : | ₹ 2,190.2 Cr |
| Net Profit(TTM) | : | ₹ 292.6 Cr |
| EPS (TTM) | : | ₹ 18.0 |
| P/E (TTM) | : | 18.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | -1.7% | 1% | -26.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.8% | -7% | 14.3% |
| DIVIS LABORATORIES | -3.4% | 0.4% | 58.4% |
| TORRENT PHARMACEUTICALS | -2.7% | -3.6% | 36% |
| CIPLA | -3.9% | -4.7% | -10.1% |
| DR REDDYS LABORATORIES | 3% | 6.1% | -3.8% |
| MANKIND PHARMA | 1.2% | 4.4% | 0.6% |
| LUPIN | -2.7% | -6.2% | 3.5% |
| ZYDUS LIFESCIENCES | -1.4% | 0.1% | 15.5% |
FDC Revenues
[BOM: 531599|NSE : FDC]
| Y-o-Y | 2.98 % |
| 5 Yr CAGR | 9.18 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,171 Cr | 2.98 | |
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | - | |
FDC Operating Profit
[BOM: 531599|NSE : FDC]
| Y-o-Y | 6.56 % |
| 5 Yr CAGR | 8.07 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹346 Cr | 6.56 | |
| Mar2025 | ₹325 Cr | -4.06 | |
| Mar2024 | ₹339 Cr | 35.64 | |
| Mar2023 | ₹250 Cr | -1.61 | |
| Mar2022 | ₹254 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 3.44 % |
| 5 Yr CAGR | -1.01 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 15.94% | 3.44 | |
| Mar2025 | 15.41% | -11.54 | |
| Mar2024 | 17.42% | 24.52 | |
| Mar2023 | 13.99% | -15.72 | |
| Mar2022 | 16.6% | - | |
FDC Profit After Tax
[BOM: 531599|NSE : FDC]
| Y-o-Y | 5.49 % |
| 5 Yr CAGR | 6.79 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹281 Cr | 5.49 | |
| Mar2025 | ₹267 Cr | -12.55 | |
| Mar2024 | ₹305 Cr | 57.22 | |
| Mar2023 | ₹194 Cr | -10.33 | |
| Mar2022 | ₹216 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 2.69 % |
| 5 Yr CAGR | -2.16 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 12.59 % | 2.69 | |
| Mar2025 | 12.26 % | -19.66 | |
| Mar2024 | 15.26 % | 44.78 | |
| Mar2023 | 10.54 % | -23.29 | |
| Mar2022 | 13.74 % | - | |
FDC Earnings Per Share (EPS)
[BOM: 531599|NSE : FDC]
| Y-o-Y | 5.49 % |
| 5 Yr CAGR | 7.76 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 | 5.49 | |
| Mar2025 | ₹16 | -12.54 | |
| Mar2024 | ₹19 | 60.17 | |
| Mar2023 | ₹12 | -8.74 | |
| Mar2022 | ₹13 | - | |
FDC Return on Capital Employed (ROCE)
[BOM: 531599|NSE : FDC]
| Y-o-Y | -3.57 % |
| 5 Yr CAGR | 0.24 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 15.93% | -3.57 | |
| Mar2025 | 16.52% | -15.80 | |
| Mar2024 | 19.62% | 47.85 | |
| Mar2023 | 13.27% | -15.91 | |
| Mar2022 | 15.78% | - | |
FDC Share Price vs Sensex
| Current Share Price | : | ₹335.6 |
| Current MarketCap | : | ₹ 5,462.8 Cr |
| Updated EOD on | : | Oct 01,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -1.7% |
1% |
-26.8% |
| SENSEX | -2.3% |
-6.6% |
-12% |
FDC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | -2.9% | -6.2% | -5% |
| BSE HEALTHCARE | -3.8% | -3.2% | 12.6% |
No NSE index found
You may also like the below Video Courses
FAQ about FDC Financials
How the annual revenues of FDC have changed ?
The Revenues of FDC have increased by 2.98% YoY .
How the Earnings per Share (EPS) of FDC have changed?
The Earnings Per Share (EPS) of FDC has increased by 5.49 % YoY .
Check out Intrinsic Value of Peers of FDC
Compare Stock Analytics of Peers of FDC
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
